Frank Czubayko

5.2k citations
53 papers · 4.1k indexed · 1 hit paper · h-index 34
Topics
RNA Interference and Gene Delivery (17 papers)Proteoglycans and glycosaminoglycans research (15 papers)Monoclonal and Polyclonal Antibodies Research (14 papers)

In The Last Decade

Frank Czubayko

52 papers receiving 4.0k citations

Hit Papers

RNAi-mediated gene-targeting through systemic application...20042026201120182004100200300400500

Peers

Frank Czubayko
Comparison fields: 5 of 121
  • Molecular Biology 2.9k
  • Cancer Research 611
  • Genetics 576
  • Oncology 493
  • Biomaterials 474
Replace Masamitsu Tanaka with:
Masamitsu Tanaka Japan
Fernando Larcher Spain
Hans‐Peter Elsässer Germany
Antonio Mario Tamburro Italy
Roger L. Kaspar United States
In-San Kim South Korea
Ishan Capila United States
Xia Zhao China
W. Andrew Yeudall United States
Kevin J. Yarema United States
Frank Czubayko relative to Masamitsu Tanaka Japan Masamitsu Tanaka's profile →
Citations per field
00.5×3.1×
Masamitsu Tanaka · 1×
Citations per year

Countries citing papers authored by Frank Czubayko

Since Specialization
Citations

This map shows the geographic impact of Frank Czubayko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Czubayko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Czubayko more than expected).

Fields of papers citing papers by Frank Czubayko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Czubayko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Czubayko. The network helps show where Frank Czubayko may publish in the future.

Co-authorship network of co-authors of Frank Czubayko

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Czubayko. A scholar is included among the top collaborators of Frank Czubayko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Czubayko. Frank Czubayko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 74
2 91
3 20
4 25
5 56
6 15
7 29
8 34
9 48
10 33
11 59
12 16
13 42
14 30
15 56
16 34
17 24
18
Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.
173
19 13
20 15

About Frank Czubayko

Frank Czubayko is a scholar working on Immunology and Allergy, Cell Biology and Molecular Biology, having authored 53 papers that have together received 4.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (17 papers), Proteoglycans and glycosaminoglycans research (15 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). The work is most often cited by research in Molecular Biology (2.9k citations), Cancer Research (611 citations) and Immunology and Allergy (228 citations). Frank Czubayko has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Achim Aigner, Anton Wellstein, Thomas Kissel, Anastasia Malek, Sabrina Höbel, Marius Grzelinski, Guy Berchem, Anke M. Schulte, Udo Bakowsky and Anna T. Riegel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026